Epidemiology and Screening of Colorectal Cancer



Colorectal cancer (CRC) represents an important health problem in Western countries. In 2009, there were 147,000 newly diagnosed cases of CRC and nearly 50,000 deaths associated with this disease [1]. In Europe, almost 413,000 individuals are newly diagnosed with CRC, and about half of these patients will die of the disease, making CRC the second leading cause of cancer deaths in both Europe and the United States [2].


Familial Adenomatous Polyposis Adenomatous Polyposis Coli Lynch Syndrome Fecal Occult Blood Test Adenomatous Polyp 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin. 2009;59:225–249.CrossRefPubMedGoogle Scholar
  2. 2.
    Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol. 2007 Mar;18(3):581–592.CrossRefPubMedGoogle Scholar
  3. 3.
    Weir HK, Thun MJ, Hankey BF, et al. Annual report to the nation on the status of cancer, 1975–2000, featuring the uses of surveillance data for cancer prevention and control. J Natl Cancer Inst. 2003;95:1276–1299.PubMedGoogle Scholar
  4. 4.
    Giardiello FM, Trimbath JD. Peutz–Jeghers Syndrome and Management Recommendations. Clin Gastroenterol Hepatol. 2006;4:408–415.CrossRefPubMedGoogle Scholar
  5. 5.
    Kohlmann W, Gruber SB. Hereditary non-polyposis colon cancer. In: Pagon RA, Bird TC, Dolan CR, Stephens K, editors. GeneReviews [Internet]. Seattle: University of Washington, Seattle, WA; 1993–2004 Feb 05 [updated 2006 Nov 29] http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene.Google Scholar
  6. 6.
    Crocetti E, Capocaccia R, Casella C, et al. Population-based incidence and mortality cancer trends (1986–1997) from the network of Italian cancer registries. Eur J Cancer Prev. 2004;13:287–295.CrossRefPubMedGoogle Scholar
  7. 7.
    Gatta G, Ciccolallo L, Capocaccia R, et al. Differences in colorectal cancer survival between European and US populations: the importance of sub-site and morphology. Eur J Cancer. 2003;39:2214–2222.CrossRefPubMedGoogle Scholar
  8. 8.
    Beggs AD, Latchford AR, Vasen HF, Moslein G, Alonso A. Peutz–Jeghers syndrome: a systematic review and recommendations for management. Gut. 2010;59:975–986.CrossRefPubMedGoogle Scholar
  9. 9.
    Minami Y, Nishino Y, Tsubono Y, Tsuji I, Hisamichi S. Increase of colon and rectal cancer incidence rates in Japan: trends in incidence rates in Miyagi Prefecture, 1959–1997. J Epidemiol. 2006;16:240–248.CrossRefPubMedGoogle Scholar
  10. 10.
    Levi F, Lucchini F, Negri E, Zatonski W, Boyle P, La Vecchia C. Trends in cancer mortality in the European Union and accession countries, 1980–2000. Ann Oncol. 2004;15:1425–1431.CrossRefPubMedGoogle Scholar
  11. 11.
    Goh KL, Quek KF, Yeo GT, et al. Colorectal cancer in Asians: a demographic and anatomic survey in Malaysian patients undergoing colonoscopy. Aliment Pharmacol Ther. 2005;22:859–864.CrossRefPubMedGoogle Scholar
  12. 12.
    Ladabaum U, Song K. Projected national impact of colorectal cancer screening on clinical and economic outcomes and health services demand. Gastroenterology. 2005;129:1151–1162.CrossRefPubMedGoogle Scholar
  13. 13.
    Lansdorp-Vogelaar I, van Ballegooijen M, Zauber AG, Habbema JD, Kuipers EJ. Effect of rising chemotherapy costs on the cost savings of colorectal cancer screening. J Natl Cancer Inst. 2009;101:1412–1422.CrossRefPubMedGoogle Scholar
  14. 14.
  15. 15.
    Imperiale TF, Wagner DR, Lin CY, Larkin GN, Rogge JD, Ransohoff DF. Results of screening colonoscopy among persons 40 to 49 years of age. N Engl J Med. 2002;346:1781–1785.CrossRefPubMedGoogle Scholar
  16. 16.
    Mitchell RJ, Campbell H, Farrington SM, Brewster DH, Porteous ME, Dunlop MG. Prevalence of family history of colorectal cancer in the general population. Br J Surg. 2005;92:1161–1164.CrossRefPubMedGoogle Scholar
  17. 17.
    Johns LE, Houlston RS. A systematic review and meta-analysis of familial colorectal cancer risk. Am J Gastroenterol. 2001;96:2992–3003.CrossRefPubMedGoogle Scholar
  18. 18.
    Stoffel E, Mukherjee B, Raymond VM, et al. Calculation of risk of colorectal and endometrial cancer among patients with Lynch syndrome. Gastroenterology. 2009;137:1621–1627.CrossRefPubMedGoogle Scholar
  19. 19.
    Grover S, Syngal S. Risk assessment, genetic testing, and management of Lynch syndrome. J Natl Compr Canc Netw. 2010;8:98–105.PubMedGoogle Scholar
  20. 20.
    Canavan C, Abrams KR, Mayberry J. Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn’s disease. Aliment Pharmacol Ther. 2006;23:1097–1104.CrossRefPubMedGoogle Scholar
  21. 21.
    Regula J, Rupinski M, Kraszewska E, et al. Colonoscopy in colorectal-cancer screening for detection of advanced neoplasia. N Engl J Med. 2006;355:1863–1872.CrossRefPubMedGoogle Scholar
  22. 22.
    Rex DK, Kahi CJ, Levin B, et al. Guidelines for colonoscopy surveillance after cancer resection: a consensus update by the American Cancer Society and US Multi-Society Task Force on Colorectal Cancer. CA Cancer J Clin. 2006;56:160–167.CrossRefPubMedGoogle Scholar
  23. 23.
    Morson B. President’s address. The polyp-cancer sequence in the large bowel. Proc R Soc Med. 1974;67:451–457.PubMedGoogle Scholar
  24. 24.
    Winawer SJ, Zauber AG, Ho MN, et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med. 1993;329:1977–1981.CrossRefPubMedGoogle Scholar
  25. 25.
    Citarda F, Tomaselli G, Capocaccia R, Barcherini S, Crespi M; Italian Multicentre Study Group. Efficacy in standard clinical practice of colonoscopic polypectomy in reducing colorectal cancer incidence. Gut. 2001;48:812–815.CrossRefPubMedGoogle Scholar
  26. 26.
    Stryker SJ, Wolff BG, Culp CE, Libbe SD, Ilstrup DM, MacCarty RL. Natural history of untreated colonic polyps. Gastroenterology. 1987;93:1009–1013.PubMedGoogle Scholar
  27. 27.
    Atkin WS, Morson BC, Cuzick J. Long-term risk of colorectal cancer after excision of rectosigmoid adenomas. N Engl J Med. 1992;326:658–662.CrossRefPubMedGoogle Scholar
  28. 28.
    Muller AD, Sonnenberg A. Prevention of colorectal cancer by flexible endoscopy. A case-control study of 32,702 veterans. Ann Intern Med. 1995;123:904–910.PubMedGoogle Scholar
  29. 29.
    Chen CD, Yen MF, Wang WM, et al. A case-cohort study for the disease natural history of adenoma–carcinoma and de novo carcinoma and surveillance of colon and rectum after polypectomy: implication for efficacy of colonoscopy. Br J Cancer 2003;88:1866–1873.CrossRefPubMedGoogle Scholar
  30. 30.
    Church JM. Clinical significance of small colorectal polyps. Dis Colon Rectum. 2004;47:481–485.CrossRefPubMedGoogle Scholar
  31. 31.
    Butterly LF, Chase MP, Pohl H, Fiarman GS. Prevalence of clinically important histology in small adenomas. Clin Gastroenterol Hepatol. 2006;4:343–348.CrossRefPubMedGoogle Scholar
  32. 32.
    Eide TJ. Risk of colorectal cancer in adenoma-bearing individuals within a defined population. Int J Cancer. 1986;38:173–176.CrossRefPubMedGoogle Scholar
  33. 33.
    Nusko G, Mansmann U, Partzsch U, et al. Invasive carcinoma in colorectal adenomas: multivariate analysis of patient and adenoma characteristics. Endoscopy. 1997;29:626–631.CrossRefPubMedGoogle Scholar
  34. 34.
    Soetikno RM, Lin OS, Heidenreich PA, Young HS, Blackstone MO. Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a metaanalysis. Gastrointest Endosc. 2002;56:48–54.CrossRefPubMedGoogle Scholar
  35. 35.
    Gschwantler M, Kriwanek S, Langner E, et al. High-grade dysplasia and invasive carcinoma in colorectal adenomas: a multivariate analysis of the impact of adenoma and patient characteristics. Eur J Gastroenterol Hepatol. 2002;14:183–188.CrossRefPubMedGoogle Scholar
  36. 36.
    Heuschen UA, Hinz U, Allemeyer EH, et al. Backwash ileitis is strongly associated with colorectal carcinoma in ulcerative colitis. Gastroenterology. 2001;120:841–847.CrossRefPubMedGoogle Scholar
  37. 37.
    Itzkowitz SH, Present DH. Consensus conference: Colorectal cancer screening and surveillance in inflammatory bowel disease. Inflamm Bowel Dis. 2005;11:314–321.CrossRefPubMedGoogle Scholar
  38. 38.
    Bernstein CN, Shanahan F, Weinstein WM. Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis? Lancet. 1994;343:71–74.CrossRefPubMedGoogle Scholar
  39. 39.
    Hassan C, Pickhardt PJ, Kim DH, et al. Systematic review: distribution of advanced neoplasia according to polyp size at screening colonoscopy. Aliment Pharmacol Ther. 2010;31:210–217.PubMedGoogle Scholar
  40. 40.
    Hoff G, Foerster A, Vatn MH, Sauar J, Larsen S. Epidemiology of polyps in the rectum and colon. Recovery and evaluation of unresected polyps 2 years after detection. Scand J Gastroenterol. 1986;21:853–862.CrossRefPubMedGoogle Scholar
  41. 41.
    Ries LA, Kosary CL, Hankey BF, et al, eds. SEER Cancer Statistics Review, 1973–1994. Bethesda, MD: National Institutes of Health, National Cancer Institute; 1997. NIH Publication No. 97–2789.Google Scholar
  42. 42.
    U.S. Preventive Services Task Force. Guide to Clinical Preventive Services.2nd ed. Alexandria, VA: International Medical Publishing; 1996.Google Scholar
  43. 43.
    Pignone M, Saha S, Hoerger T, et al. Cost-effectiveness analyses of colorectal cancer screening: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2002;137:96–104.PubMedGoogle Scholar
  44. 44.
    Hardcastle JD, Chamberlain JO, Robinson MHE, et al. Randomised controlled trial of faecaloccultblood screening for colorectal cancer. Lancet. 1996;348:1472–1477.CrossRefPubMedGoogle Scholar
  45. 45.
    Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomised study of screening for colorectal cancer with faecaloccultblood test. Lancet. 1996;348:1467–1471.CrossRefPubMedGoogle Scholar
  46. 46.
    Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med. 1993;328:1365–1371.CrossRefPubMedGoogle Scholar
  47. 47.
    Towler B, Irwig L, Glasziou P, et al. A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, hemoccult. BMJ. 1998;317:559–565.PubMedGoogle Scholar
  48. 48.
    Nakajima M, Saito H, Soma Y, Sobue T, Tanaka M, Munakata A. Prevention of advanced colorectal cancer by screening using the immunochemical faecal occult blood test: a case-control study. Br J Cancer. 2003;89:23–28.CrossRefPubMedGoogle Scholar
  49. 49.
    Saito H, Soma Y, Koeda J, et al. Reduction in risk of mortality from colorectal cancer by fecal occult blood screening with immunochemical hemagglutination test. A case-control study. Int J Cancer. 1995;61:465–469.CrossRefPubMedGoogle Scholar
  50. 50.
    Saito H, Soma Y, Nakajima M, et al. A case-control study evaluating occult blood screening for colorectal cancer with hemoccult test and an immunochemical hemagglutination test. Oncol Rep. 2000;7:815–819.PubMedGoogle Scholar
  51. 51.
    Allison JE, Tekawa IS, Ransom LJ, Adrain AL. A comparison of fecal occult-blood tests for colorectal-cancer screening. N Engl J Med. 1996;334:155–159.CrossRefPubMedGoogle Scholar
  52. 52.
    Selby JV, Friedman GD, Quesenberry CP Jr, Weiss NS. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med. 1992;326:653–657.CrossRefPubMedGoogle Scholar
  53. 53.
    Newcomb PA, Storer BE, Morimoto LM, Templeton A, Potter JD. Long-term efficacy of sigmoidoscopy in the reduction of colorectal cancer incidence. J Natl Cancer Inst. 2003;16;95:622–625.Google Scholar
  54. 54.
    Lieberman DA, Weiss DG, Bond JH, Ahnen DJ, Garewal H, Chejfec G. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380. N Engl J Med. 2000;343:162–168.CrossRefPubMedGoogle Scholar
  55. 55.
    Schoenfeld P, Cash B, Flood A, et al. Colonoscopic screening of average-risk women for colorectal neoplasia. N Engl J Med. 2005;352:2061–2068.CrossRefPubMedGoogle Scholar
  56. 56.
    Atkin WS, Hart A, Edwards R, et al. Uptake, yield of neoplasia, and adverse effects of flexible sigmoidoscopy screening. Gut. 1998;42:560–565.CrossRefPubMedGoogle Scholar
  57. 57.
    Segnan N, Senore C, Andreoni B, et al. Baseline findings of the Italian multicenter randomized controlled trial of “once-only sigmoidoscopy”—SCORE. J Natl Cancer Inst. 2002;94:1763–1772.PubMedGoogle Scholar
  58. 58.
    Kramer BS, Gohagan J, Prorok PC, Smart C. A National Cancer Institute sponsored screening trial for prostatic, lung, colorectal, and ovarian cancers. Cancer. 1993;71:589–593.CrossRefPubMedGoogle Scholar
  59. 59.
    Hoff G, Grotmol T, Skovlund E, Bretthauer M; Norwegian Colorectal Cancer Prevention Study Group. Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomised controlled trial. BMJ. 2009; 338.Google Scholar
  60. 60.
    Atkin WS, Edwards R, Kralj-Hans I, Wooldrage K, Hart AR, et al. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet. 2010;375(9726):1624–1633.CrossRefPubMedGoogle Scholar
  61. 61.
    Fenlon HM, McAneny DB, Nunes DP, Clarke PD, Ferrucci JT. Occlusive colon carcinoma: virtual colonoscopy in the preoperative evaluation of the proximal colon. Radiology. 1999;210:423–428.PubMedGoogle Scholar
  62. 62.
    Cotton PB, Durkalski VL, Pineau BC, et al. Computed tomographic colonography (virtual colonoscopy): a multicenter comparison with standard colonoscopy for detection of colorectal neoplasia. JAMA. 2004;291:1713–1719.CrossRefPubMedGoogle Scholar
  63. 63.
    Rockey DC, Paulson E, Niedzwiecki D, et al. Analysis of air contrast barium enema, computed tomographic colonography, and colonoscopy: prospective comparison. Lancet. 2005;365:301–311.Google Scholar
  64. 64.
    Rutter M, Saunders B, Wilkinson K, et al. Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology. 2004;126(2):451–459.CrossRefPubMedGoogle Scholar
  65. 65.
    Gupta RB, Harpaz N, Itzkowitz S, et al. Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study. Gastroenterology. 2007;133:1099–1105.CrossRefPubMedGoogle Scholar
  66. 66.
    Kornbluth A, Sachar DB; Practice Parameters Committee of the American College of Gastroenterology. Ulcerative colitis practice guidelines in adults: American College Of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol. 2010;105:501–523.CrossRefPubMedGoogle Scholar
  67. 67.
    Kiesslich R, Fritsch J, Holtmann M, et al. Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis. Gastroenterology. 2003;124:880–888.CrossRefPubMedGoogle Scholar
  68. 68.
    Marion JF, Waye JD, Present DH, et al. Chromoendoscopy-targeted biopsies are superior to standard colonoscopic surveillance for detecting dysplasia in inflammatory bowel disease patients: a prospective endoscopic trial. Am J Gastroenterol. 2008;103:2342–2349.CrossRefPubMedGoogle Scholar
  69. 69.
    Levin B, Lieberman DA, McFarland B, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology. 2008;134:1570–1595.CrossRefPubMedGoogle Scholar
  70. 70.
    Whitlock EP, Lin JS, Liles E, Beil TL, Fu R. Screening for colorectal cancer: a targeted, updated systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2008;149:638–658.PubMedGoogle Scholar
  71. 71.
    Hara AK, Johnson CD, MacCarty RL, Welch TJ. Incidental extracolonic findings at CT colonography. Radiology. 2000;215:353–357.PubMedGoogle Scholar
  72. 72.
    Chambers WM, Warren BF, Jewell DP, Mortensen NJ. Cancer surveillance in ulcerative colitis. Br J Surg. 2005;92:928–936.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  • Cesare Hassan
  • Gabriel D. Lang
  • David T. Rubin
    • 1
  1. 1.Section of Gastroenterology, Hepatology and Nutrition, Department of MedicineUniversity of Chicago Medical CenterChicagoUSA

Personalised recommendations